WO2003091277A3 - Haplotypes du gene cetp - Google Patents

Haplotypes du gene cetp Download PDF

Info

Publication number
WO2003091277A3
WO2003091277A3 PCT/US2003/013288 US0313288W WO03091277A3 WO 2003091277 A3 WO2003091277 A3 WO 2003091277A3 US 0313288 W US0313288 W US 0313288W WO 03091277 A3 WO03091277 A3 WO 03091277A3
Authority
WO
WIPO (PCT)
Prior art keywords
haplotypes
cetp
gene
disclosed
cetp gene
Prior art date
Application number
PCT/US2003/013288
Other languages
English (en)
Other versions
WO2003091277A2 (fr
Inventor
Alison E Anastasio
Anne Chew
Amir Kazemi
Michael Lachowicz
Helen H Lee
Katie E Parks
Nathan Petersen
Eileen Rounds
Elizabeth Ann Sausker
Charles Tirrell
Original Assignee
Genaissance Pharmaceuticals
Alison E Anastasio
Anne Chew
Amir Kazemi
Michael Lachowicz
Helen H Lee
Katie E Parks
Nathan Petersen
Eileen Rounds
Elizabeth Ann Sausker
Charles Tirrell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Alison E Anastasio, Anne Chew, Amir Kazemi, Michael Lachowicz, Helen H Lee, Katie E Parks, Nathan Petersen, Eileen Rounds, Elizabeth Ann Sausker, Charles Tirrell filed Critical Genaissance Pharmaceuticals
Priority to AU2003239189A priority Critical patent/AU2003239189A1/en
Publication of WO2003091277A2 publication Critical patent/WO2003091277A2/fr
Publication of WO2003091277A3 publication Critical patent/WO2003091277A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne de nouveaux variants génétiques du gène de la protéine de transfert d'ester de cholestéryle (CETP). L'invention concerne également divers génotypes, haplotypes, et paires d'haplotypes existant dans la population des Etats-unis pour le gène CETP. L'invention concerne en outre des compositions et des méthodes d'haplotypage et/ou de génotypage du gène CETP chez un individu. L'invention concerne enfin des polynucléotides définis par les haplotypes mentionnés ci-dessus.
PCT/US2003/013288 2002-04-26 2003-04-28 Haplotypes du gene cetp WO2003091277A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003239189A AU2003239189A1 (en) 2002-04-26 2003-04-28 Haplotypes of the cetp gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37579102P 2002-04-26 2002-04-26
US60/375,791 2002-04-26

Publications (2)

Publication Number Publication Date
WO2003091277A2 WO2003091277A2 (fr) 2003-11-06
WO2003091277A3 true WO2003091277A3 (fr) 2005-04-14

Family

ID=29270700

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2003/013346 WO2003091698A2 (fr) 2002-04-26 2003-04-28 Marqueurs genetiques de la cetp reperant des modifications, imputables aux statines, affectant le cholesterol hdl
PCT/US2003/013288 WO2003091277A2 (fr) 2002-04-26 2003-04-28 Haplotypes du gene cetp

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2003/013346 WO2003091698A2 (fr) 2002-04-26 2003-04-28 Marqueurs genetiques de la cetp reperant des modifications, imputables aux statines, affectant le cholesterol hdl

Country Status (2)

Country Link
AU (2) AU2003228761A1 (fr)
WO (2) WO2003091698A2 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE NCBI [online] 29 March 2003 (2003-03-29), DOE JOINT GENOME INSTITUTE: "Direct submission", XP002985097, accession no. STN Database accession no. AC012181 *
DATABASE NCBI [online] September 2000 (2000-09-01), DOE JOINT GENOME INSTITUTE: "Sequencing of human chromosome 16", XP002985096, accession no. STN Database accession no. AC010550 *

Also Published As

Publication number Publication date
AU2003228761A1 (en) 2003-11-10
WO2003091698A2 (fr) 2003-11-06
AU2003239189A1 (en) 2003-11-10
AU2003239189A8 (en) 2003-11-10
WO2003091277A2 (fr) 2003-11-06
AU2003228761A8 (en) 2003-11-10
WO2003091698A3 (fr) 2005-04-21

Similar Documents

Publication Publication Date Title
WO2001090122A3 (fr) Haplotypes du gene ctla4
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2003091277A3 (fr) Haplotypes du gene cetp
WO2002018414A3 (fr) Haplotypes du gène bf
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2002090512A3 (fr) Haplotypes du gene nnmt
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2001087909A3 (fr) Haplotypes du gene aanat
WO2002002580A3 (fr) Haplotypes du gene etfb
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2001092278A3 (fr) Haplotypes du gene rlbp1
WO2002040502A3 (fr) Haplotypes du gene de la lipase hormono-sensible
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2002030950A3 (fr) Haplotypes du gene fy
WO2002042320A3 (fr) Haplotypes du gene de glutathione reductase
WO2001094362A3 (fr) Haplotypes du gene acp2
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2002010190A3 (fr) Haplotypes du gene il12b
WO2001087907A3 (fr) Haplotypes du gene de l'osm
WO2002016398A3 (fr) Haplotypes du gene bmpr2
WO2002012499A3 (fr) Haplotypes du gene ntf3

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP